Chimeric Antigen Receptor T Cell Therapy and Its Significance in Multiple Myeloma

Multiple myeloma (MM) has a five-year prevalence worldwide of 230,000 people and is known as the second most common hematological malignancy within the United States. Extensive research has been conducted to gain a wide range of treatment strategies, providing hope to these patients. Combination the...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Curēus (Palo Alto, CA) CA), 2021-06, Vol.13 (6), p.e15917-e15917
Hauptverfasser:	Padda, Jaskamal, Khalid, Khizer, Zubair, Ujala, Peethala, Mounika M, Kakani, Varsha, Goriparthi, Lakshmi, Almanie, Abdulelah H, Cooper, Ayden Charlene, Jean-Charles, Gutteridge
Format:	Artikel
Sprache:	eng
Schlagworte:	Hematology Internal Medicine Oncology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!